Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Addus HomeCare (ADUS) stock in plain English

Free brief · no signupStart here
ADUSPublished Nov 12, 2026
Addus HomeCare Corp
Healthcare · Medical Care Facilities
Provides personal care assistance, home health nursing, and hospice services to elderly and disabled individuals.
Assets:
24 US statesdelivers care across a multi-state footprint of regional branch offices
33,000 caregiversemployed to deliver non-medical daily living and clinical home support
Three core clinical divisionscovers non-medical personal care, clinical home health, and hospice services
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

73
OPS ScoreOperating finances
Latest quote
+0.18%$121.07
$2.26B
20.2×
$1.50B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 12, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was ADUS. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Addus HomeCare (ADUS) do?

Addus HomeCare Corp (ADUS) is a U.S.-listed company in Healthcare (Medical Care Facilities). What it does: Provides personal care assistance, home health nursing, and hospice services to elderly and disabled individuals. Coordinates in-home personal care and hospice across twenty-four states using proprietary scheduling and compliance. It is worth $2.26B on the market and sold $1.50B over the last year.

Market cap
$2.26B
P/E ratio
20.2×
Annual sales
$1.50B
Sector
Healthcare
Industry
Medical Care Facilities
Brief updated
Nov 12, 2026

Brands and businesses behind ADUS

  • Queen City Hospice: Provides end of life palliative and hospice care to patients and earns revenue through Medicare reimbursements.
  • JourneyCare: Delivers adult and pediatric hospice services across Illinois, generating revenue primarily from government Medicare payments.
  • Tennessee Quality Care: Offers clinical home health, private duty, and hospice care, collecting payments from Medicare, Medicaid, and insurers.

ADUS’s flags, in plain English

Each flag is a number from Addus HomeCare’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 12, 2026.

Low debt

Low debt, only 6% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Stupid Cash

Can pay this year's bills 1.6 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Still Climbing

Sales up 13.2% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Worth a Look

Medicaid programs fund most of the company's personal care services, leaving operations exposed to state budget adjustments and reimbursement freezes. Something here could change the picture, so it is worth reading next to the good news.

1 more green flag open with the free trial. Try it free for 7 days.

Questions about ADUS

How big is Addus HomeCare?

Addus HomeCare’s market cap is $2.26B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.50B: what customers paid the company over the last year, before any costs.

What is ADUS’s P/E ratio?

ADUS’s P/E ratio is 20.2×. Investors pay about 20.2 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with ADUS?

The first risk note on the card is Worth a Look, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Addus HomeCare’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. ADUS’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card